Log In
Print this Print this

Tumor BRACAnalysis CDx

Also known as: BRACAnalysis CDx

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionIn vitro diagnostic that qualitatively detects and classifies variants in the protein coding regions and intron/exon boundaries of the breast cancer 1 early onset (BRCA1) and BRCA2 genes from whole blood for use as companion diagnostic
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsCompanion diagnostic for olaparib; Companion diagnostic for poly(ADP-ribose) polymerase (PARP) inhibitors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today